WHAT'S HAPPENING AT PROJECT ALS
Join the 2021 Don’t Talk-a-Thon!
Christine Taylor & Ben Stiller want YOU Click Here To Join! How the Don’t Talk-a-Thon Started Avery Niedrowski lost her Grandpa John to ALS when
Support Project ALS Research by Drinking ONEHOPE Wine
ONEHOPE is a charity-based wine company that gives back with every purchase. If you buy ONEHOPE wine via this link, 10% of of your purchase will go
The Hunt for ALS Biomarkers: Fat?
Updated October 2021: Check out new results from Dr. Estela Area-Gomez in Nature Scientific Reports The entire ALS community—patients, researchers, biotechs, doctors, regulators alike—agree on one thing:
Trivia Night! February 25th
Join us in teams of up to 8 people on Thursday, February 25th, at 7pm ET! Register here: https://fundraise.projectals.org/trivia225
Cooking for a Cure
Rebecca Charles, Tom Colicchio, Bobby Flay, and Claudia Fleming prepare special dishes and share their recipes in memory of Gerry Hayden and in support of
Spread the love…
From now through February 14th, get your loved one a hand-poured, sustainably-crafted candle and use our code at checkout to support Project ALS research. Click
The Hermstad Legacy: Advances in Treatments for ALS
FEBRUARY 4, 2021
11am-4pm ET
FREE TO REGISTER
CORE Update: Drug Discovery Progress at the Kirchhoff Family Drug Screening Unit
The core of THE CORE—its primary drug assessment platform—is the Kirchhoff Family Drug Screening Unit, where CORE researchers develop new cellular models of ALS, and
Neuroscience Publishes Special Issue Commemorating Project ALS Research Leader’s Legacy
The current issue of Neuroscience journal is dedicated to the staggering contributions to science made by longtime Project ALS Research Advisory Board Chair Thomas M. Jessell, PhD, before his death from the rare neurodegenerative disease progressive supranuclear palsy on April 28, 2019, at 67.
Project ALS – Winter 2020 News
While COVID-19 profoundly affected its day-to-day operations, The Project ALS Therapeutics Core at Columbia generated new approaches to disease modeling and genetic engineering technologies in 2020.
Meet the Project ALS Family: Q&A with Prosetin Toxicologist Dr. Merrill Osheroff
When Project ALS decided to move prosetin to clinical trial independently, we were newcomers to drug development. Our first task: assembling a team of experts